Trial Profile
A clinical study of Lactobacillus reuteri Protectis, as a probiotic, for the treatment of patients diagnosed with functional constipation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Jul 2015
Price :
$35
*
At a glance
- Drugs Limosilactobacillus reuteri (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors BioGaia
- 24 Jul 2015 New trial record